ANEB Anebulo Pharmaceuticals
- 1.960
- +0.110+5.95%
- 1.960
- 0.0000.00%
Anebulo Pharmaceuticals News
Anebulo Pharmaceuticals | 10-K: FY2024 Annual Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHAH BIMAL R.
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lawler Joseph F.
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kupchyk Areta
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Calloway Nathaniel
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Kenneth
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Cundy Kenneth C
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cundy Kenneth C
Anebulo Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Analysis
Price Target
No Data
No Data